IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
$1.02B
Mr. Fred M. Schwarzer J.D.
242.00
Mountain View, CA
Sep 18, 2019
-4.83
$-3.57
1.79
7.06
-7,571.35%
-4.85
-0.20
8.73
360.27
7.06
-65.50%
-119.02%
Similar stocks (12)
Cerevel Therapeutics Holdings, Inc.
CERE
Revolution Medicines, Inc.
RVMD
Avidity Biosciences, Inc.
RNA
Cullinan Oncology, Inc.
CGEM
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
Monte Rosa Therapeutics, Inc.
GLUE
Design Therapeutics, Inc.
DSGN
Black Diamond Therapeutics, Inc.
BDTX
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
Passage Bio, Inc.
PASG
ETF Exposure (27)
Loncar Cancer Immunotherapy ETF
CNCR
3.23%
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.579%
iShares Micro-Cap ETF
IWC
0.04117%
iShares Russell 2000 Growth ETF
IWO
0.01113%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00624%
Schwab U.S. Small-Cap ETF
SCHA
0.0029538928%
ProShares Ultra Russell2000
UWM
0.0023049605924121757%
iShares Russell 2000 Value ETF
IWN
0.00176%
ProShares UltraPro Russell2000
URTY
0.0011357663840312574%
ProShares Hedge Replication ETF
HDG
9.56820228953258e-4%
iShares Russell 3000 ETF
IWV
3.9e-4%
Schwab U.S. Broad Market ETF
SCHB
3.518425e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Cerevel Therapeutics Holdings, Inc.
CERE
Revolution Medicines, Inc.
RVMD
Avidity Biosciences, Inc.
RNA
Cullinan Oncology, Inc.
CGEM
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
Monte Rosa Therapeutics, Inc.
GLUE
Design Therapeutics, Inc.
DSGN
Black Diamond Therapeutics, Inc.
BDTX
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
Passage Bio, Inc.
PASG
ETF Exposure (27)
Loncar Cancer Immunotherapy ETF
CNCR
3.23%
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.579%
iShares Micro-Cap ETF
IWC
0.04117%
iShares Russell 2000 Growth ETF
IWO
0.01113%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00624%
Schwab U.S. Small-Cap ETF
SCHA
0.0029538928%
ProShares Ultra Russell2000
UWM
0.0023049605924121757%
iShares Russell 2000 Value ETF
IWN
0.00176%
ProShares UltraPro Russell2000
URTY
0.0011357663840312574%
ProShares Hedge Replication ETF
HDG
9.56820228953258e-4%
iShares Russell 3000 ETF
IWV
3.9e-4%
Schwab U.S. Broad Market ETF
SCHB
3.518425e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%